Peptide Microarray Discovery via Light-Directed Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for discovering peptide binders to proteins are expensive, time-consuming, prone to contamination, and lack a systematic approach to identify optimal binders, often failing to distinguish between specific and non-specific binders, and require laborious optimization techniques.
Innovation Solution
A method involving peptide microarrays where a comprehensive population of peptides is immobilized, with overlapping binding identified, followed by maturation and extension processes to optimize peptide sequences for high specificity and affinity to target proteins, using maskless light-directed technology for efficient synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If display technology methods (phage display, ribosome display, mRNA-display) are used to identify peptide binders, then peptide binders can be identified through combinatorial libraries, but the methods are expensive, time-consuming, and prone to contamination
Solution Approach 1:
The patent replaces the complex biological display technology systems (phage, ribosome, mRNA display) with a simplified peptide array system that uses solid-phase peptide synthesis. This substitution eliminates the need for cellular components and complex selection procedures, thereby reducing contamination risks and time consumption while maintaining identification accuracy.
Solution Approach 2:
The patent creates comprehensive peptide libraries by synthesizing and immobilizing numerous peptide sequences on solid supports. These peptide arrays serve as replicable copies of potential binder libraries, allowing multiple experiments to be conducted simultaneously without the need for repeated biological selection processes, thus reducing time and improving reliability.
2Ease of operation
If display methods select only a few winners, then selection is simplified, but other potentially strong binders are missed and no mechanism discriminates between specific and non-specific binders
Solution Approach 1:
The patent employs exhaustive screening of comprehensive peptide libraries rather than selecting only a few winners. By testing all or most peptides in the library against the target protein, the method ensures that no potentially strong binders are missed and allows discrimination between specific and non-specific interactions through comparative analysis of binding patterns across the entire library.
3Reliability
If display methods are used, then peptide binders can be identified, but laborious trial and error optimization is required for each target protein
Solution Approach 1:
The patent performs preliminary comprehensive screening of extensive peptide libraries before optimization. By identifying multiple candidate binders with high specificity in the initial screening phase, the method reduces the need for subsequent trial-and-error optimization. The systematic approach allows for more direct and efficient optimization of identified candidates.
4Reliability
If peptide arrays are used with comprehensive peptide population, then multiple specific binders can be discovered, but manufacturing cost and complexity increase
Solution Approach 1:
The patent divides the comprehensive peptide library into multiple separate peptide arrays, each containing a manageable subset of peptides. This segmentation allows for simplified manufacturing and handling of individual arrays while maintaining the ability to screen through the entire library by using multiple arrays in parallel or sequence, thus reducing the complexity of any single array while preserving discovery accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the rapid and reliable discovery of multiple specific peptide binders for various target proteins, improving the efficiency and accuracy of peptide binder identification and reducing the need for costly and time-consuming optimization processes.
Implementation Method 1
maskless light-directed technology for efficient synthesis
Implementation Method 2
overlapping binding identified, followed by maturation and extension processes to optimize peptide sequences for high specificity and affinity to target proteins
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention provides novel peptide binders for streptavidin (SA), Taq polymerase and several human proteins: Prostate Specific Antigen (PSA), thrombin, Tumor Necrosis Factor Alpha (TNFα), and Urokinase-type Plasminogen Activator (uPA).